Related references
Note: Only part of the references are listed.Pyrrolo[2,3-b]pyridine-3-one derivatives as novel fibroblast growth factor receptor 4 inhibitors for the treatment of hepatocellular carcinoma
Qiaomei Jin et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2021)
Discovery and optimization of novel pyrazole-benzimidazole CPL304110, as a potent and selective inhibitor of fibroblast growth factor receptors FGFR (1-3)
Abdellah Yamani et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)
Protein-ligand interaction-guided discovery of novel VEGFR-2 inhibitors
Yanmin Zhang et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Molecular dynamics simulation and 3D-pharmacophore analysis of new quinoline-based analogues with dual potential against EGFR and VEGFR-2
Neda Fayyazi et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2020)
Design, synthesis, molecular modeling, in vivo studies and anticancer evaluation of quinazolin-4(3H)-one derivatives as potential VEGFR-2 inhibitors and apoptosis inducers
Hazem A. Mahdy et al.
BIOORGANIC CHEMISTRY (2020)
Design, synthesis, biological evaluation and molecular modeling study of new thieno[2,3-d]pyrimidines with anti-proliferative activity on pancreatic cancer cell lines
Mohamed S. H. Salem et al.
BIOORGANIC CHEMISTRY (2020)
Design, synthesis and biological evaluation of novel 1H-1,2,4-triazole, benzothiazole and indazole-based derivatives as potent FGFR1 inhibitors viafragment-based virtual screening
Jian Liu et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Design, synthesis, and molecular docking of novel 2-arylbenzothiazole multiangiokinase inhibitors targeting breast cancer
Heba T. Abdel-Mohsen et al.
ARCHIV DER PHARMAZIE (2020)
AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1 alpha/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo
Peng-Chao Zhang et al.
BIOCHEMICAL PHARMACOLOGY (2020)
Discovery of 4,6-pyrimidinediamine derivatives as novel dual EGFR/FGFR inhibitors aimed EGFR/FGFR1-positive NSCLC
Zixin Xie et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
The inhibition profiles of 4'-acylpyrrole-5-fluoroindolin-2-ones with a C-3' side chain for VEGFR2, PDGFR-β, and FGFR-1 protein kinases
Jiann-Jyh Huang et al.
JOURNAL OF THE CHINESE CHEMICAL SOCIETY (2020)
Targeting Receptor Tyrosine Kinase VEGFR-2 in Hepatocellular Cancer: Rational Design, Synthesis and Biological Evaluation of 1,2-Disubstituted Benzimidazoles
Heba T. Abdel-Mohsen et al.
MOLECULES (2020)
Structure-based drug design of 1,3,5-triazine and pyrimidine derivatives as novel FGFR3 inhibitors with high selectivity over VEGFR2
Ikumi Kuriwaki et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Synthesis and molecular docking study of new pyrazole derivatives as potent anti-breast cancer agents targeting VEGFR-2 kinase
Dina H. Dawood et al.
BIOORGANIC CHEMISTRY (2020)
Novel Anticancer Fused Pyrazole Derivatives as EGFR and VEGFR-2 Dual TK Inhibitors
Nashwa M. Saleh et al.
FRONTIERS IN CHEMISTRY (2020)
Discovery and pharmacological characterization of AZD3229, a potent KIT/PDGFRα inhibitor for treatment of gastrointestinal stromal tumors
Erica Banks et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Design, synthesis and pharmacological evaluation of 4-(3-chloro-4-(3-cyclopropylthioureido)-2-fluorophenoxy)-7-methoxyquinoline-6-carboxamide (WXFL-152): a novel triple angiokinase inhibitor for cancer therapy
Yuqin Yao et al.
ACTA PHARMACEUTICA SINICA B (2020)
Novel VEGFR-2 inhibitors with anN-acylhydrazone scaffold
Fernanda P. Pauli et al.
ARCHIV DER PHARMAZIE (2020)
Structural modifications of indolinones bearing a pyrrole moiety and discovery of a multi-kinase inhibitor with potent antitumor activity
Mingze Qin et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Discovery of N-substituted-3-phenyl-1,6-naphthyridinone derivatives bearing quinoline moiety as selective type II c-Met kinase inhibitors against VEGFR-2
Hongchuang Xu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2020)
Scaffold hopping and redesign approaches for quinazoline based urea derivatives as potent VEGFR-2 inhibitors
Soha R. Abd El Hadi et al.
BIOORGANIC CHEMISTRY (2020)
Exploration of carbamide derived pyrimidine-thioindole conjugates as potential VEGFR-2 inhibitors with anti-angiogenesis effect
Sravani Sana et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Evolutionary chemical binding similarity approach integrated with 3D-QSAR method for effective virtual screening
Prasannavenkatesh Durai et al.
BMC BIOINFORMATICS (2020)
Discovery of new quinazolin-4(3H)-ones as VEGFR-2 inhibitors: Design, synthesis, and anti-proliferative evaluation
Ibrahim H. Eissa et al.
BIOORGANIC CHEMISTRY (2020)
Design and synthesis of new 1,6-dihydropyrimidin-2-thio derivatives targeting VEGFR-2: Molecular docking and antiproliferative evaluation
Adel A. Marzouk et al.
BIOORGANIC CHEMISTRY (2020)
Selective VEGFR-2 inhibitors: Synthesis of pyridine derivatives, cytotoxicity and apoptosis induction profiling
Amal AbdelHaleem et al.
BIOORGANIC CHEMISTRY (2020)
Design, synthesis, molecular docking and anticancer evaluations of 5-benzylidenethiazolidine-2,4-dione derivatives targeting VEGFR-2 enzyme
Khaled El-Adl et al.
BIOORGANIC CHEMISTRY (2020)
Synthesis and evaluation of new thiourea derivatives as antitumor and antiangiogenic agents
Wenjing Bai et al.
TETRAHEDRON LETTERS (2020)
Discovery of novel indolyl-1,2,4-triazole hybrids as potent vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitors with potential anti-renal cancer activity
Sami A. Al-Hussain et al.
BIOORGANIC CHEMISTRY (2020)
Novel 2-indolinone thiazole hybrids as sunitinib analogues: Design, synthesis, and potent VEGFR-2 inhibition with potential anti-renal cancer activity
Huda K. Mahmoud et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Novel benzimidazole derivatives as anti-cervical cancer agents of potential multi-targeting kinase inhibitory activity
Eman A. Abd El-Meguid et al.
ARABIAN JOURNAL OF CHEMISTRY (2020)
Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors
Nashwa M. Saleh et al.
BIOORGANIC CHEMISTRY (2020)
Discovery of novel anti-angiogenesis agents. Part 10: Multi-target inhibitors of VEGFR-2, Tie-2 and EphB4 incorporated with 1,2,3-triazol
Xiaoyan Pan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Discovery of novel anti-angiogenesis agents. Part 9: Multiplex inhibitors suppressing compensatory activations of RTKs
Yuanyuan Shan et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Probing 2H-Indazoles as Templates for SGK1, Tie2, and SRC Kinase Inhibitors
Jens Schoene et al.
CHEMMEDCHEM (2019)
Inhibition of COX-2, mPGES-1 and CYP4A by isoliquiritigenin blocks the angiogenic Akt signaling in glioma through ceRNA effect of miR-194-5p and lncRNA NEAT1
Chenlong Wang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Imaging the Dynamic Interaction Between Sprouting Microvessels and the Extracellular Matrix
Adam Rauff et al.
FRONTIERS IN PHYSIOLOGY (2019)
Hematopoietic growth factors and tumor angiogenesis
Domenico Ribatti et al.
CANCER LETTERS (2019)
Hypoxia: Overview on Hypoxia-Mediated Mechanisms with a Focus on the Role of HIF Genes
Alexandru Andrei Tirpe et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
EphB4 mediates resistance to antiangiogenic therapy in experimental glioma
Christian Uhl et al.
ANGIOGENESIS (2018)
FGF-dependent metabolic control of vascular development
Pengchun Yu et al.
NATURE (2017)
PFKFB3 promotes proliferation, migration and angiogenesis in nasopharyngeal carcinoma
Miao Gu et al.
JOURNAL OF CANCER (2017)
Expression and purification of functional PDGF receptor beta
Qingbin Shang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy
Anna Rita Cantelmo et al.
CANCER CELL (2016)
Direct Melanoma Cell Contact Induces Stromal Cell Autocrine Prostaglandin E2-EP4 Receptor Signaling That Drives Tumor Growth, Angiogenesis, and Metastasis
Masaki Inada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
N-O-Isopropyl Sulfonamido-Based Hydroxamates as Matrix Metalloproteinase Inhibitors: Hit Selection and in Vivo Antiangiogenic Activity
Elisa Nuti et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Intermittent Hypoxia Selects for Genotypes and Phenotypes That Increase Survival, Invasion, and Therapy Resistance
Daniel Verduzco et al.
PLOS ONE (2015)
COX-2 Inhibition Potentiates Antiangiogenic Cancer Therapy and Prevents Metastasis in Preclinical Models
Lihong Xu et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Role of PFKFB3-Driven Glycolysis in Vessel Sprouting
Katrien De Bock et al.
CELL (2013)
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Rakesh K. Jain
JOURNAL OF CLINICAL ONCOLOGY (2013)
Cytochrome P450 ω-hydroxylase promotes angiogenesis and metastasis by upregulation of VEGF and MMP-9 in non-small cell lung cancer
Wei Yu et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES
Shom Goel et al.
PHYSIOLOGICAL REVIEWS (2011)
Overlooking Evolution: A Systematic Analysis of Cancer Relapse and Therapeutic Resistance Research
C. Athena Aktipis et al.
PLOS ONE (2011)
Macrophage Diversity Enhances Tumor Progression and Metastasis
Bin-Zhi Qian et al.
CELL (2010)
Heterozygous Deficiency of PHD2 Restores Tumor Oxygenation and Inhibits Metastasis via Endothelial Normalization
Massimiliano Mazzone et al.
CELL (2009)
Adverse effects of anticancer agents that target the VEGF pathway
Helen X. Chen et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Oxygen sensing by metazoans: The central role of the HIF hydroxylase pathway
William G. Kaelin et al.
MOLECULAR CELL (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
Reactive oxygen species and cellular oxygen sensing
Timothy P. Cash et al.
FREE RADICAL BIOLOGY AND MEDICINE (2007)
Effect of heterogeneous vasculature on interstitial transport within a solid tumor
Jianbing Zhao et al.
MICROVASCULAR RESEARCH (2007)
VEGF/VEGFR signalling as a target for inhibiting angiogenesis
Alex Kiselyov et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2007)
Matrix metalloproteinases and angiogenesis
JE Rundhaug
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2005)
Share Paper
